首頁 > 市場調查報告書 > 製藥

再生醫學細胞療法

幹細胞市場規模、佔有率和成長分析（按治療方法、細胞類型、應用、技術、最終用戶和地區分類）—2026-2033年產業預測

市場調查報告書

商品編碼

1904842

幹細胞市場規模、佔有率和成長分析（按治療方法、細胞類型、應用、技術、最終用戶和地區分類）—2026-2033年產業預測

Stem Cell Market Size, Share, and Growth Analysis, By Therapy Type (Allogeneic, Autologous), By Cell Type, By Application, By Technology, By End-User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 275 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球幹細胞市場規模將達到 148.2 億美元，到 2025 年將達到 165.1 億美元，到 2033 年將達到 391.5 億美元，在預測期（2026-2033 年）內，複合年成長率為 11.4%。

全球幹細胞市場正經歷顯著成長，這主要得益於臨床試驗數量的增加和幹細胞療法的日益普及。研究活動的激增，尤其是在應對醫療挑戰方面，正為間質幹細胞療法等創新應用鋪平道路，這些療法可用於治療多種疾病。人們對臍帶幹細胞益處的認知不斷提高，以及對再生醫學的強勁需求，正在推動該領域的投資。儘管政府資助在開發慢性病創新治療方法繼續發揮關鍵作用，但高成本和複雜的監管等挑戰仍然存在。儘管存在這些障礙，但整體前景仍然樂觀，因為研發投入和主要參與者之間的合作有望進一步擴大市場潛力並改善患者的治療效果。

全球幹細胞市場促進因素

癌症、糖尿病和心血管疾病等慢性疾病發病率的不斷上升，顯著推動了幹細胞療法的需求成長。幹細胞移植、輸注療法以及各種以幹細胞為基礎的介入措施等治療方法，作為應對這些健康挑戰的有效方案，正日益受到歡迎。尤其值得一提的是，幹細胞療法作為一種非手術方法，在緩解骨關節炎引起的膝關節疼痛方面獲得了廣泛認可。隨著越來越多的患者和醫療服務提供者尋求先進且有效的治療方案，對這些創新治療方法的需求不斷成長，也凸顯了推動全球幹細胞市場擴張的更廣泛趨勢。

限制全球幹細胞市場的因素

影響全球幹細胞市場的主要限制因素是幹細胞療法（包括移植、注射和各種治療）的高成本。這一經濟障礙阻礙了這些先進治療方法的廣泛應用和普及，尤其是在經濟資源有限的發展中地區。因此，許多患者無力負擔這些治療費用，直接限制了市場的整體成長潛力。缺乏負擔得起的幹細胞療法加劇了醫療保健方面的不平等，阻礙了該領域的進步，並最終使患者無法充分受益於幹細胞創新。

全球幹細胞市場趨勢

全球幹細胞市場正經歷著向個人化醫療的顯著轉變，治療方法正朝著更個人化的方向發展，以滿足每位患者的個別特徵。幹細胞研究和技術的進步使得根據患者獨特的基因組成和病歷客製化治療方案成為可能。這種個人化不僅提高了治療效果，還有助於改善患者的預後，從而推動了包括關節疾病在內的各個醫學領域對個人化治療的需求。隨著醫療保健行業不斷優先考慮以患者為中心的解決方案，對個人化幹細胞療法的關注預計將會擴大，從而塑造再生醫學的未來並推動市場成長。

北美（按治療方法、細胞類型、應用、技術和最終用戶分類）
- 美國
- 加拿大
歐洲（依治療方法、細胞類型、應用、技術、最終用戶分類）
- 英國
- 德國
- 西班牙
- 法國
- 義大利
- 其他歐洲地區
亞太地區（按治療方法、細胞類型、應用、技術和最終用戶分類）
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲（按治療方法、細胞類型、應用、技術、最終用戶分類）
- 巴西
- 墨西哥
- 其他拉丁美洲地區
中東和非洲（按治療方法、細胞類型、應用、技術和最終用戶分類）
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭對手儀錶板

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）

主要企業簡介

Thermo Fisher Scientific, Inc.
The following companies are listed for indicative purposes only. Similar information will be provided for each, with detailed financial data available exclusively for publicly listed companies.
Mesoblast Ltd
CRISPR Therapeutics
Merck KGaA
Lonza Group
Becton Dickinson（BD）
Sartorius AG
Miltenyi Biotec
Bio-Rad Laboratories
Bio-Techne
Eppendorf AG
Corning Inc.
Takara Bio Inc.
Fujifilm Cellular Dynamics
Stemcell Technologies
American CryoStem Corporation
CellGenix GmbH
Medipost
Holostem Terapie Avanzate
Catalent Inc.

結論與建議

簡介目錄

Product Code: SQMIG35D2059

Global Stem Cell Market size was valued at USD 14.82 Billion in 2024 and is poised to grow from USD 16.51 Billion in 2025 to USD 39.15 Billion by 2033, growing at a CAGR of 11.4% during the forecast period (2026-2033).

The global stem cell market is witnessing significant growth, fueled by increasing clinical trials and the wider adoption of stem cell therapies. The surge in research initiatives, particularly in response to healthcare challenges, is paving the way for innovative applications, such as mesenchymal stem cell therapies for various conditions. Enhanced awareness regarding the advantages of umbilical stem cells and strong demand for regenerative treatments are driving investments in the sector. While government funding continues to play a crucial role in advancing innovative treatments for chronic diseases, challenges such as high costs and regulatory complexities persist. Despite these obstacles, the overall landscape remains promising, as research and development efforts, along with collaboration among key players, are set to further expand the market's potential and improve patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Stem Cell market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Stem Cell Market Segments Analysis

Global Stem Cell Market is segmented by Therapy Type, Cell Type, Application, Technology, End-User and region. Based on Therapy Type, the market is segmented into Allogeneic and Autologous. Based on Cell Type, the market is segmented into Adult Stem Cells (ASCs), Human Embryonic Stem Cells (HESCs), Induced Pluripotent Stem Cells (IPSCs) and Very Small Embryonic-Like Stem Cells (VSELs). Based on Application, the market is segmented into Regenerative Medicine, Drug Discovery & Development and Clinical Research. Based on Technology, the market is segmented into Cell Acquisition, Cell Production, Cryopreservation and Expansion and Sub-Culture. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Cell Banks, Academic & Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Stem Cell Market

The growing incidence of chronic illnesses, including cancer, diabetes, and cardiovascular conditions, is significantly boosting the demand for stem cell therapies. Treatments such as stem cell transplants, injections, and various stem cell-based interventions are becoming more prevalent as viable solutions for these health challenges. Notably, stem cell therapy has emerged as a popular non-surgical approach for alleviating knee pain associated with osteoarthritis. This escalating demand for innovative therapeutic options underscores a broader trend that is poised to propel the expansion of the global stem cell market, as more patients and healthcare providers seek advanced and effective treatment alternatives.

Restraints in the Global Stem Cell Market

A significant constraint affecting the global stem cell market is the elevated cost tied to stem cell therapies, encompassing procedures such as transplants, injections, and various treatments. This financial barrier hampers the widespread acceptance and utilization of these advanced therapies, especially in developing regions where economic resources are limited. As a result, numerous patients find these options financially unattainable, which directly constrains the overall growth potential of the market. The inability to access affordable stem cell treatments perpetuates healthcare disparities and inhibits advancements within the sector, ultimately hindering the realization of the full benefits of stem cell innovations.

Market Trends of the Global Stem Cell Market

The global stem cell market is witnessing a notable shift towards personalized medicine, as therapies evolve to cater to individual patient profiles. Advancements in stem cell research and technology are facilitating the creation of tailored treatments that align with a patient's unique genetic composition and medical history. This customization not only enhances treatment efficacy but also improves patient outcomes, driving demand for individualized therapies across various medical conditions, including joint issues. As healthcare continues to prioritize patient-centric solutions, the focus on personalized stem cell therapies is poised to expand, shaping the future of regenerative medicine and augmenting market growth.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impact Factor
Top Investment Pockets
Market Attractiveness Index
Market Ecosystem
PESTEL Analysis
Regulatory Landscape
Case Study Analysis
Value Chain Analysis
Patent Analysis
Technology Analysis
Clinical Trial Analysis
Disease Epidemiology

Global Stem Cell Market Size by Therapy Type (2019-2032)

Market Overview
Allogeneic
Autologous

Global Stem Cell Market Size by Cell Type (2019-2032)

Market Overview
Adult Stem Cells (ASCs)
- Hematopoietic
- Mesenchymal
- Neural
- Epithelial/Skin
- Other ASCs
Human Embryonic Stem Cells (HESCs)
Induced Pluripotent Stem Cells (IPSCs)
Very Small Embryonic-Like Stem Cells (VSELs)

Global Stem Cell Market Size by Application (2019-2032)

Market Overview
Regenerative Medicine
- Neurology
- Orthopaedics
- Musculoskeletal Disorders
- Oncology
- Haematology
- Cardiovascular
- Metabolic Disorders
- Liver Disorders
- Incontinence
- Other Regenerative Medicines
Drug Discovery & Development
Clinical Research

Global Stem Cell Market Size by Technology (2019-2032)

Market Overview
Cell Acquisition
- Bone Marrow Harvest
- Umbilical Cord Blood
- Apheresis
Cell Production
- Therapeutic Cloning
- In-vitro Fertilization
- Cell Culture
- Isolation
Cryopreservation
Expansion and Sub-Culture

Global Stem Cell Market Size by End-User (2019-2032)

Market Overview
Pharmaceutical & Biotechnology Companies
Hospitals & Cell Banks
Academic & Research Institutes
Others

Global Stem Cell Market Size (2019-2032)

North America (By Therapy Type, By Cell Type, By Application, By Technology, & By End-User)
- US
- Canada
Europe (By Therapy Type, By Cell Type, By Application, By Technology, & By End-User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific (By Therapy Type, By Cell Type, By Application, By Technology, & By End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America (By Therapy Type, By Cell Type, By Application, By Technology, & By End-User)
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa (By Therapy Type, By Cell Type, By Application, By Technology, & By End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Dashboard

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025

Key Company Profiles

Thermo Fisher Scientific, Inc.
- Company Overview
- Product Portfolio Overview
- Financial Overview
- Key Developments
The following companies are listed for indicative purposes only. Similar information will be provided for each, with detailed financial data available exclusively for publicly listed companies.
Mesoblast Ltd
CRISPR Therapeutics
Merck KGaA
Lonza Group
Becton Dickinson (BD)
Sartorius AG
Miltenyi Biotec
Bio-Rad Laboratories
Bio-Techne
Eppendorf AG
Corning Inc.
Takara Bio Inc.
Fujifilm Cellular Dynamics
Stemcell Technologies
American CryoStem Corporation
CellGenix GmbH
Medipost
Holostem Terapie Avanzate
Catalent Inc.